Press release
Analysis of Segments and Major Growth Areas in the Analgesics Market
Analgesics Market
Projected Market Size and Growth Trajectory of the Analgesics Market
The global analgesics market is forecasted to reach a value of $132.6 billion by 2030, growing at a compound annual growth rate (CAGR) of 3.4%. Several factors contribute to this anticipated growth, including progress in personalized medicine approaches, increased research and development focused on alternatives to opioids, the expansion of e-pharmacies and digital health platforms, a growing elderly population, and the adoption of smart manufacturing technologies within the pharmaceutical sector. Important trends expected to influence the market during this period include personalized pain management therapies, advances in both opioid and non-opioid drug development, wider availability of hospital and retail pharmacy distribution channels, heightened demand for treatments addressing chronic and cancer-related pain, and greater public awareness surrounding the safe use of analgesics.
Download a free sample of the analgesics market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Corporations Driving the Analgesics Market Forward
The analgesics industry is dominated by several prominent companies known for their extensive research, development, and distribution capabilities. These key players include Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P., Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co. Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, and Innovative Med Concepts LLC.
Significant Acquisition Strengthening Market Position in 2023
In December 2023, Wellnex Life Limited, an Australian health and wellness company, completed the acquisition of Pain Away Ltd. for $22 million. This strategic purchase marks a transformative step for Wellnex, aligning with its long-term vision to build a strong presence in defensive healthcare sectors. Pain Away Ltd., a U.S.-based firm specializing in topical pain relief products, complements Wellnex's portfolio, enhancing its competitive stance within the analgesics market.
View the full analgesics market report:
https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Growing Emphasis on Combination Analgesics as a Market Trend
Pharmaceutical companies are increasingly focusing on developing combination analgesics to improve therapeutic effectiveness and differentiate their product offerings. Combination analgesics blend two or more pain-relieving agents, targeting pain through multiple biological pathways for enhanced relief. A notable example occurred in February 2024, when UK-based Hikma Pharmaceuticals plc launched COMBOGESIC IV in the United States. This intravenous formulation combines acetaminophen (paracetamol) and ibuprofen, providing dual-action pain relief by harnessing both analgesic and anti-inflammatory effects. Designed as a new non-opioid pain management option, COMBOGESIC IV delivers 1,000 mg of acetaminophen and 300 mg of ibuprofen. It offers faster onset and over twice the pain relief compared to its individual components, along with a favorable safety profile, addressing growing concerns related to opioid use.
Expansion of Product Categories and Channels within the Analgesics Market
The global analgesics market is segmented across multiple categories to capture its diverse product range and distribution methods. These segments include:
1) By Type: Non-opioids and Opioids
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Drug Stores
3) By Application: Internal Analgesics and External Analgesics
Within non-opioids, further subcategories include Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), and Salicylates. The opioid segment is divided into natural opioids, semi-synthetic opioids, and synthetic opioids, reflecting the variety of compounds used for pain management.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Analysis of Segments and Major Growth Areas in the Analgesics Market here
News-ID: 4495271 • Views: …
More Releases from The Business Research Company
Future Perspectives: Key Trends Shaping the Tendinopathy Market Up to 2030
The tendinopathy market is positioned for significant expansion over the coming years as advancements in treatment and technology continue to evolve. This sector's growth is being driven by increasing research investments and an enhanced focus on personalized and minimally invasive care options. Below, we explore the market's size projections, leading companies, emerging trends, and segmentation in detail.
Projected Growth Trajectory of the Tendinopathy Market Through 2030
The tendinopathy market is…
Key Companies Leading Innovation and Growth in the Aptamers Market
The aptamers market is on the verge of remarkable growth as it gains traction in various healthcare and research applications. Driven by technological breakthroughs and expanding collaborations, this sector is poised for significant advancements by 2030. Here's an in-depth look at the market size, key players, innovations, and segmentation shaping its future.
Projected Growth and Market Size of the Aptamers Industry
The aptamers market is anticipated to experience rapid expansion,…
In-Depth Examination of Segments, Industry Developments, and Key Players in the …
The telepsychiatry market is rapidly evolving, driven by technological advancements and growing recognition of mental health needs. As healare systems increasingly embrace digital solutions, telepsychiatry is becoming a vital tool to improve access to psychiatric care. Below, we explore the market's size, key players, emerging trends, and segmentation to understand its promising future.
Projected Growth and Size of the Telepsychiatry Market by 2030
The telepsychiatry market is on track for…
Antivenom Market Overview, Key Trends, and Insights on Top Players
The antivenom market is on track for notable expansion over the coming years, driven by technological innovations and increasing healthcare investments worldwide. With rising demand for effective treatments against venomous bites, the industry is evolving with new approaches that promise to enhance patient care and accessibility. Let's explore the expected market growth, key players, emerging trends, and segment classifications shaping the future of this vital sector.
Projected Growth and Market Size…
More Releases for Pharma
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
